Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	156
Overall Study	STARTED	2 mg Baricitinib	156
Overall Study	STARTED	4 mg Baricitinib	234
Overall Study	Received at Least One Dose of Study Drug	Placebo	155
Overall Study	Received at Least One Dose of Study Drug	2 mg Baricitinib	156
Overall Study	Received at Least One Dose of Study Drug	4 mg Baricitinib	234
Overall Study	COMPLETED	Placebo	0
Overall Study	COMPLETED	2 mg Baricitinib	0
Overall Study	COMPLETED	4 mg Baricitinib	0
Overall Study	NOT COMPLETED	Placebo	156
Overall Study	NOT COMPLETED	2 mg Baricitinib	156
Overall Study	NOT COMPLETED	4 mg Baricitinib	234

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03899259/flow